The size of the global pharmaceutical ingredient market is due to reach ~USD 250bn by 2025, owing to the rise in prominence of chronic diseases and viral and bacterial infections. This has led to a growth in R&D investment, as well as a rise in demand for generic and branded medicine ingredients.

China and India offer the highest potential for growth of the pharmaceutical ingredients market, as high manufacturing costs worldwide are pushing manufacturers to seek cost-optimized, sustainable, production processes.

The innovative active pharmaceuticals ingredients (API) segment is expected to experience continued growth due to increased FDA approval of new molecular formulations and high prices when compared to the generic API segment.

Client Cases

Talk to our Consulting leaders about how we can add value
Contact us to make strategy & innovation work for you